Gail K. Mattson

发表

beta-alanine dipeptides as MC4R agonists.

J. Macor, R. Ruel, D. Shi, 2003, Bioorganic & medicinal chemistry letters.

Dihydropyridine neuropeptide Y Y(1) receptor antagonists.

Astrid A. Ortiz, M. Arcuri, Scott W. Martin, 2002, Bioorganic & medicinal chemistry letters.

Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.

Astrid A. Ortiz, I. Antal-Zimanyi, Christina Leahy, 2008, European journal of pharmacology.

Isosteric N‐Arylpiperazine Replacements in a Series of Dihydropyridine NPY1 Receptor Antagonists.

D. Longhi, I. Antal-Zimanyi, H. Wong, 2005 .

Synthesis and evaluation of carbamate and aryl ether substituted pyrazinones as corticotropin releasing factor-1 (CRF₁) receptor antagonists.

Vijay T. Ahuja, J. Macor, T. Molski, 2016, Bioorganic & medicinal chemistry letters.

Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.

B. Beno, M. Cunningham, T. Molski, 2005, Journal of medicinal chemistry.

Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.

B. Beno, J. Macor, T. Molski, 2010, Journal of medicinal chemistry.

Application of solution-phase parallel synthesis to preparation of trisubstituted 1,2,4-triazoles.

Scott W. Martin, Ling Chen, I. Antal-Zimanyi, 2004, Journal of combinatorial chemistry.

Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists.

Astrid A. Ortiz, I. Antal-Zimanyi, S. Rassnick, 2006, Bioorganic & medicinal chemistry.

Discovery and Preclinical Evaluation of BMS-955829, a Potent Positive Allosteric Modulator of mGluR5.

J. Macor, Amy Easton, Anand Balakrishnan, 2016, ACS medicinal chemistry letters.

Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles.

T. Molski, R. Mattson, N. Lodge, 2010, Bioorganic & medicinal chemistry letters.

Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box.

J. Macor, Amy Easton, Anand Balakrishnan, 2016, Bioorganic & medicinal chemistry letters.

Conformationally restricted homotryptamines. Part 6: indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.

J. Macor, T. Molski, R. Mattson, 2013, Bioorganic & medicinal chemistry letters.

Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs).

J. Macor, T. Molski, R. Mattson, 2005, Bioorganic & medicinal chemistry letters.

Ex vivo assessment of binding site occupancy of monoamine reuptake inhibitors: Methodology and biological significance

R. Pieschl, T. Molski, N. Lodge, 2008, Neuropharmacology.

β-Alanine dipeptides as MC4R agonists

R. Ruel, D. Shi, I. Zimanyi, 2003 .

Potential CRF1R PET imaging agents: 1-fluoroalkylsubstituted 5-halo-3-(arylamino)pyrazin-2(1H)-ones.

Vijay T. Ahuja, J. Macor, D. Zuev, 2013, Bioorganic & medicinal chemistry letters.

Potential CRF1R PET imaging agents: N-fluoroalkyl-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethyl-N-alkylpyrazolo[1,5-a][1,3,5]triazin-4-amines.

J. Macor, D. Zuev, R. Mattson, 2011, Bioorganic & medicinal chemistry letters.

Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists.

Astrid A. Ortiz, O. Flint, M. Deshpande, 2012, ACS medicinal chemistry letters.

[18F](R)-5-chloro-1-(1-cyclopropyl-2-methoxyethyl)-3-(4-(2-fluoroethoxy)-2,5-dimethyl phenylamino)pyrazin-2(1H)-one: introduction of N3-phenylpyrazinones as potential CRF-R1 PET imaging agents.

Vijay T. Ahuja, J. Macor, T. Molski, 2012, Bioorganic & medicinal chemistry letters.

Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists.

Joseph Payne, Vijay T. Ahuja, Yue-Zhong Shu, 2009, Journal of medicinal chemistry.

Differentially functionalized diamines as novel ligands for the NPY2 receptor.

M. Deshpande, L. Iben, Gail K. Mattson, 2003, Bioorganic & medicinal chemistry letters.

Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.

J. Macor, T. Molski, R. Mattson, 2009, Bioorganic & medicinal chemistry letters.

Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.

B. Beno, T. Molski, R. Mattson, 2007, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.

Vijay T. Ahuja, J. Macor, T. Molski, 2010, Bioorganic & medicinal chemistry letters.